CathWorks

CathWorks is a medical technology company focused on enhancing clinical decision-making in the field of cardiology with its FFRangio System. The system uses artificial intelligence and advanced computational science to extract physiological information from routine angiograms, helping interventional cardiologists assess coronary physiology with precision. CathWorks has received regulatory approvals in the United States, Israel, and Japan, and the FFRangio System is positioned as a potential new standard in physiology assessment for coronary artery disease. The company is involved in strategic partnerships to expand its reach and impact, notably with a recent partnership involving Medtronic.